Results 51 to 60 of about 38,263 (215)

Infective Endocarditis: A Review of the Past and Present, and a Look into the Future

open access: yesCardiovascular Innovations and Applications, 2017
Infective endocarditis is a lethal and challenging multifaceted disease that can involve any vascularized system. We believe that multimodality imaging is invaluable to provide a comprehensive diagnosis.
Eric I-Hun Jeng   +4 more
doaj   +1 more source

What anabolic–androgenic steroids reveal about the limits of current harm reduction models

open access: yesAddiction, EarlyView.
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski   +2 more
wiley   +1 more source

Infective Endocarditis Presenting as Polymyalgia Rheumatica: Case Report

open access: yesThe Turkish Journal of Gastroenterology, 2011
Infective endocarditis is a bacterial infection of the cardiac valves and endocardium with a high level of mortality and morbidity. Due to such high mortality and morbidity risks, early and accurate diagnosis bears great importance.
Cihat ÖZTÜRK   +3 more
doaj  

The impact of harm reduction interventions on injection‐related bacterial infections among people who inject drugs: A systematic review

open access: yesAddiction, EarlyView.
Abstract Background and aims Injection‐related bacterial infections represent a major but under‐recognised health issue among people who inject drugs (PWID). Harm reduction interventions (HRIs) like needle and syringe programmes (NSP) and opioid agonist treatment (OAT) could mitigate their burden.
Anthony Cousien   +7 more
wiley   +1 more source

Superantigens Are Critical for Staphylococcus aureus Infective Endocarditis, Sepsis, and Acute Kidney Injury

open access: yesmBio, 2013
Infective endocarditis and kidney infections are serious complications of Staphylococcus aureus sepsis. We investigated the role of superantigens (SAgs) in the development of lethal sepsis, infective endocarditis, and kidney infections.
Wilmara Salgado-Pabón   +7 more
doaj   +1 more source

Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou   +5 more
wiley   +1 more source

Patterns of Surgical Prophylaxis Prescribing for Dentoalveolar Procedures in Australian Hospitals: 2016–2022

open access: yesAustralian Dental Journal, EarlyView.
ABSTRACT Background Antimicrobials are an adjunctive therapy in clinical dentistry. In dentoalveolar surgery, antimicrobials are not routinely required for surgical prophylaxis. This retrospective analysis of the Australian Surgical National Antimicrobial Prescribing Survey (Surgical NAPS) dataset aimed to evaluate the guideline compliance and ...
Jane Chen   +6 more
wiley   +1 more source

Staphylococcus lugdunensis Endocarditis in a 35-Year-Old Woman in Her 24th Week of Pregnancy

open access: yesCase Reports in Obstetrics and Gynecology, 2016
Background. Infective endocarditis is associated with considerable morbidity and mortality. Guidelines addressing prophylaxis and management of infective endocarditis do not extensively deal with concomitant pregnancy, and case reports on infective ...
Mounir Khafaga   +7 more
doaj   +1 more source

Potentially Preventable Mortality After Elective Colorectal Cancer Surgery: Insights From a National Surgical Mortality Audit

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Background Colorectal cancer (CRC) is a significant contributor to preventable deaths worldwide. The assessment of potentially avoidable mortality following elective CRC surgery has yet to be reported. The Australian and New Zealand Audit of Surgical Mortality (ANZASM) seeks to peer‐review all deaths associated with surgical care.
Sergei Bedrikovetski   +4 more
wiley   +1 more source

Long‐Term Safety and Efficacy of Obeticholic Acid in Patients With Primary Biliary Cholangitis: Final Results of the POISE Long‐Term Safety Extension

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
In the POISE open‐label extension, patients with primary biliary cholangitis with inadequate response or intolerance to ursodeoxycholic acid received long‐term obeticholic acid (OCA) treatment. Findings demonstrated a safety profile consistent with the known characteristics of OCA, with no unexpected safety signals, while supporting sustained efficacy ...
Christopher L. Bowlus   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy